Neuromyelitis Optica Spectrum Disorder Clinical Trials in Beijing
3 recruitingBeijing, China
Showing 1–3 of 3 trials
Recruiting
Phase 4
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Neuromyelitis Optica Spectrum Disorder Attack
Chinese PLA General Hospital200 enrolled1 locationNCT07410039
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Alexion Pharmaceuticals, Inc.122 enrolled33 locationsNCT05966467
Recruiting
Phase 2Phase 3
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled51 locationsNCT06413654